These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28812045)

  • 21. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
    Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
    Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure.
    Bayes-Genis A; Pascual-Figal D; Januzzi JL; Maisel A; Casas T; Valdés Chávarri M; Ordóñez-Llanos J
    Rev Esp Cardiol; 2010 Oct; 63(10):1171-8. PubMed ID: 20875357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration.
    Homsak E; Ekart R
    Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation.
    Wernly B; Lichtenauer M; Jirak P; Eder S; Reiter C; Kammler J; Kypta A; Jung C; Franz M; Hoppe UC; Landmesser U; Figulla HR; Lauten A
    Eur J Clin Invest; 2017 Feb; 47(2):149-157. PubMed ID: 28036122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia.
    Sasmaya PH; Khalid AF; Anggraeni D; Irianti S; Akbar MR
    Eur J Obstet Gynecol Reprod Biol X; 2022 Jan; 13():100140. PubMed ID: 34917932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
    Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
    Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.
    Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R
    PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
    Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke.
    Chen W; Lin A; Yu Y; Zhang L; Yang G; Hu H; Luo Y
    Clin Lab; 2018 Sep; 64(9):1349-1356. PubMed ID: 30274001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
    Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
    Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
    Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
    Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.
    Wang C; Gao L; Zhang ZG; Li YQ; Yang YL; Chang T; Zheng LL; Zhang XY; Man MH; Li LH
    Mol Neurobiol; 2016 Apr; 53(3):1509-1517. PubMed ID: 25650122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.
    Henry-Okafor Q; Collins SP; Jenkins CA; Miller KF; Maron DJ; Naftilan AJ; Weintraub N; Fermann GJ; McPherson J; Menon S; Sawyer DB; Storrow AB
    Open Biomark J; 2012 Apr; 2012(5):1-8. PubMed ID: 23439880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction.
    Shah KB; Kop WJ; Christenson RH; Diercks DB; Henderson S; Hanson K; Li SY; deFilippi CR
    Clin Chem; 2011 Jun; 57(6):874-82. PubMed ID: 21515743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of
    Jiang W; Wang X; Gao P; Li F; Lu K; Tan X; Zheng S; Pei W; An M; Li X; Hu R; Zhong Y; Zhu J; Du J; Wang Y
    Front Cardiovasc Med; 2021; 8():710425. PubMed ID: 34409081
    [No Abstract]   [Full Text] [Related]  

  • 37. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.
    Broch K; Ueland T; Nymo SH; Kjekshus J; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Cleland JG; Aukrust P; Gullestad L
    Eur J Heart Fail; 2012 Mar; 14(3):268-77. PubMed ID: 22302661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
    Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
    Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Snider J; Cohn JN
    Circ Heart Fail; 2014 May; 7(3):418-26. PubMed ID: 24622243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofilament light is associated with clinical outcome and hemorrhagic transformation in moderate to severe ischemic stroke.
    Rattanawong W; Ongphichetmetha T; Hemachudha T; Thanapornsangsuth P
    J Cent Nerv Syst Dis; 2023; 15():11795735221147212. PubMed ID: 36632518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.